F Jané

1.3k total citations
67 papers, 1.0k citations indexed

About

F Jané is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, F Jané has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 16 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in F Jané's work include Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Analytical Methods in Pharmaceuticals (9 papers). F Jané is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Analytical Methods in Pharmaceuticals (9 papers). F Jané collaborates with scholars based in Spain, Austria and Costa Rica. F Jané's co-authors include Miguel Casas, Sergi Ferré, Manel J. Barbanoj, P. Anderer, B. Saletu, Josep Maria Ustrell i Torrent, Jordi Riba, Gemma Prat, Adelaida Morte and Iñaki Izquierdo and has published in prestigious journals such as Biological Psychiatry, Brain Research and European Heart Journal.

In The Last Decade

F Jané

65 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Jané Spain 18 326 265 182 168 107 67 1.0k
Aron D. Mosnaim United States 20 378 1.2× 139 0.5× 202 1.1× 351 2.1× 77 0.7× 85 1.3k
Maria Augusta Vieira‐Coelho Portugal 26 345 1.1× 113 0.4× 208 1.1× 812 4.8× 137 1.3× 105 2.0k
Jonathan M. Oyler United States 19 420 1.3× 176 0.7× 243 1.3× 372 2.2× 19 0.2× 31 1.5k
Elliot M. Berry Israel 21 225 0.7× 166 0.6× 461 2.5× 228 1.4× 206 1.9× 49 1.4k
H. Dix Christensen United States 19 247 0.8× 62 0.2× 397 2.2× 120 0.7× 54 0.5× 57 1.2k
M. Hariharan United States 17 178 0.5× 61 0.2× 86 0.5× 311 1.9× 66 0.6× 42 1.1k
M Evans United Kingdom 17 342 1.0× 53 0.2× 191 1.0× 214 1.3× 25 0.2× 35 1.1k
S.R. Bareggi Italy 22 456 1.4× 146 0.6× 359 2.0× 347 2.1× 105 1.0× 87 1.8k
M. Reiter Germany 25 355 1.1× 63 0.2× 63 0.3× 735 4.4× 56 0.5× 116 1.9k
Young Kyu Kwon South Korea 18 201 0.6× 41 0.2× 140 0.8× 419 2.5× 131 1.2× 43 1.5k

Countries citing papers authored by F Jané

Since Specialization
Citations

This map shows the geographic impact of F Jané's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Jané with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Jané more than expected).

Fields of papers citing papers by F Jané

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Jané. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Jané. The network helps show where F Jané may publish in the future.

Co-authorship network of co-authors of F Jané

This figure shows the co-authorship network connecting the top 25 collaborators of F Jané. A scholar is included among the top collaborators of F Jané based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Jané. F Jané is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbanoj, M.J., et al.. (2006). Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers. Human Psychopharmacology Clinical and Experimental. 21(1). 13–26. 41 indexed citations
2.
3.
Casas, Miguel, et al.. (2000). Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats. European Journal of Pharmacology. 396(2-3). 93–99. 3 indexed citations
4.
5.
Casas, Miguel, Gemma Prat, Patricia Robledo, et al.. (1999). Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats. European Journal of Pharmacology. 366(1). 1–11. 16 indexed citations
6.
Morte, Adelaida, Josep M. Grinyó, R. Solà, et al.. (1999). Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Clinical Pharmacology & Therapeutics. 66(5). 485–491. 22 indexed citations
7.
Barbanoj, M.J., et al.. (1997). NO SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC DIFFERENCES OF CAPTOPRIL. Pharmacological Research. 36(1). 41–47. 6 indexed citations
8.
Jané, F. (1996). Professional prospects in clinical pharmacology. History and present situation in Spain.. PubMed. 18 Suppl C. 5–7. 1 indexed citations
9.
Borja, Javier, et al.. (1993). Evaluation of the methodological quality of clinical trial protocols. European Journal of Clinical Pharmacology. 44(4). 401–402. 5 indexed citations
10.
Torrent, Josep Maria Ustrell i, et al.. (1991). TOLERANCE AND KINETIC BEHAVIOR AFTER SINGLE AND REPEATED VAGINAL ADMINISTRATION OF SERTACONAZOLE CREAM AND TABLETS IN HEALTHY VOLUNTEERS. Current Therapeutic Research. 49(6). 1046–1060. 5 indexed citations
11.
Ramis, Joaquim, et al.. (1991). Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose. European Journal of Drug Metabolism and Pharmacokinetics. 16(4). 269–273. 20 indexed citations
12.
Jané, F, et al.. (1991). Droxicam: a pharmacological and clinical review of a new NSAID.. PubMed. 11(4). 3–9. 1 indexed citations
13.
14.
Casas, Miguel, Sergi Ferré, Josep Puig i Cadafalch, Josep M. Grau, & F Jané. (1989). Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors. Pharmacology Biochemistry and Behavior. 33(3). 609–613. 14 indexed citations
15.
Jané, F, et al.. (1989). Pharmacodynamic Effects of a Single 10-mg Dose of the Angiotensin Converting Enzyme Inhibitor Ramipril in Patients with Impaired Renal Function. Journal of Cardiovascular Pharmacology. 13. S45–S48. 2 indexed citations
16.
Torrent, Josep Maria Ustrell i, Iñaki Izquierdo, Ricardo Cabezas, & F Jané. (1989). Theophylline-Isoniazid Interaction. DICP. 23(2). 143–145. 10 indexed citations
17.
Torrent, Josep Maria Ustrell i, Iñaki Izquierdo, M.J. Barbanoj, et al.. (1988). Theophylline pharmacokinetics following single and repeated administration of slow-release capsules. European Journal of Drug Metabolism and Pharmacokinetics. 13(4). 225–230. 2 indexed citations
18.
Casas, Miguel, et al.. (1988). Theophylline reverses haloperidol-induced catalepsy in the rat possible relevance to the pharmacological treatment of psychosis. Biological Psychiatry. 24(6). 642–648. 25 indexed citations
19.
Obach, R., Javier Borja, Josep María Vallès, et al.. (1988). Lack of Correlation Between Lithium Pharmacokinetic Parameters Obtained from Plasma and Saliva. Therapeutic Drug Monitoring. 10(3). 265–268. 15 indexed citations
20.
Ramírez-Moreno, J.M., et al.. (1985). Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man.. PubMed. 23(6). 298–301. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aron D. Mosnaim Breakdown of academic impact, for papers by Maria Augusta Vieira‐Coelho Breakdown of academic impact, for papers by Jonathan M. Oyler Breakdown of academic impact, for papers by Elliot M. Berry Breakdown of academic impact, for papers by H. Dix Christensen Breakdown of academic impact, for papers by M. Hariharan Breakdown of academic impact, for papers by M Evans Breakdown of academic impact, for papers by S.R. Bareggi Breakdown of academic impact, for papers by M. Reiter Breakdown of academic impact, for papers by Young Kyu Kwon
Rankless by CCL
2026